U.S. Treasuries pared some of Wednesday's weakness that was prompted by above-consensus inflation data. The 2- and 10-year Treasury yields fell 3 basis points to 4.338% and 4.606%, respectively, ...

CRISPR booked revenue of just under $36 million. On the bottom line, CRISPR flipped to a generally accepted accounting ...

Engineering Tomorrow, a public charity dedicated to inspiring high school students to pursue a path in engineering, today announced the appointment of Sean MacCready as Director of Development. In ...

Duke University cancer researcher Prof Donald McDonnell on BTYSTE and how learning the scientific process at an early age is invaluable.

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is a pioneer in gene-editing technology, using its patented gene sequencing platform to ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

His research explores the rise of generative AI and accelerated use of AI more broadly to advance drug and scientific discovery. Reuben leads Gartner's coverage of genomics, multiomics, cell and gene ...

The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...